Sera Prognostics Inc., The Pregnancy Company® , focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that ...
Zymosense, a pioneering nanotechnology firm and the leader in mobile "mix and read" enzyme activity assays, today announced the appointment of three accomplished leaders ...
Secondary acute myeloid leukemias (sAMLs) evolving from myeloproliferative neoplasms (MPNs) associate with poor prognosis. Here authors identify RSK1 as a vulnerability for MPN and sAML and show ...
Adriana Dias and co-authors report a low-cost bioassay for the detection of low concentrations of lead in drinking water. The approach uses a genetically modified strain of Escherichia coli, which ...